Advanced Biomed Inc
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | — | — | — |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin | — | — | — |
| Operating Expenses | |||
| Research & Development | $909.8K | $880.2K | — |
| SG&A Expense | $2.1M | $1.7M | — |
| Operating Income | $-3.3M | $-2.8M | — |
| Operating Margin | — | — | — |
| Interest Expense | — | — | — |
| Pretax Income | $-3.3M | $-2.8M | — |
| Income Tax Expense | — | — | — |
| Net Income | $-3.3M | $-2.8M | — |
| Net Margin | — | — | — |
| EPS (Basic) | $-0.16 | $-0.14 | — |
| EPS (Diluted) | $-0.16 | $-0.14 | — |
| Shares Outstanding (Basic) | 20.5M | 20.0M | 100.0M |
| Shares Outstanding (Diluted) | 20.5M | 20.0M | 100.0M |
| Dividends Per Share | — | — | — |